Learn how to write a thoughtful, evidence-based comment that becomes part of the administrative record.
Banning one chemical does not go far enough. We need to ban whole-leaf natural kratom — the parent plant of 7-hydroxymitragynine (7-OH).
The FDA-sponsored clinical trial demonstrated that ordinary leaf kratom — not just extracts — produces drug liking, feeling high, and measurable 7-OH in human blood. Regulating only 7-OH while leaving whole-leaf kratom legal will not protect public health. Manufacturers can reformulate, and consumers can still access the parent plant. The evidence shows that whole-leaf kratom itself is psychoactive and carries dependence, toxicity, and abuse liability.
Don't try to cover everything. Pick 2–3 issues.
Mention scientific literature, community observations, or professional experience.
Professional comments are easier to read.
Avoid copying other comments.
Answer these questions in your comment. Each one expands with guidance on why HHS is asking.
HHS is considering whether to regulate 7-OH alone or the entire kratom plant. The FDA clinical trial showed whole-leaf kratom produces 7-OH in the body. If only 7-OH is banned, manufacturers could sell whole-leaf kratom that converts to 7-OH in the body.
HHS wants to understand whether a chemical-by-chemical approach is sufficient. As manufacturers reformulate to evade regulation, policy must be able to adapt. Whole-leaf kratom is the parent plant — banning it addresses the root source.
HHS is gathering information about where kratom is sold. Whole-leaf kratom is widely available in convenience stores, gas stations, and vape shops — often with no age verification or health warnings.
HHS wants to understand the real-world impact of whole-leaf kratom. Community observations — even without scientific citations — help agencies understand the scope of the problem.
HHS is asking the public to point them to the most compelling evidence. The FDA clinical trial, CDC mortality data, and poison center reports all document whole-leaf kratom and mitragynine harms.
HHS is weighing whether to target 7-OH alone or the parent plant. The evidence shows whole-leaf kratom and mitragynine are themselves psychoactive and carry dependence and toxicity risks.
All of the evidence on this site documents harms associated with whole-leaf kratom and mitragynine — not extracts, not 7-OH isolates. Click any card below.
Your comment matters. Every thoughtful submission helps shape federal policy.
Comment Now